Ya se produce #Soberana02 a gran escala, en @Biocen, institución científica de @BioCubaFarma con 30 años de experiencia en producción de vacunas. Un paso más hacia la ansiada inmunización de los cubanos. Que la buena noticia no nos haga bajar la guardia. #CubaViva #SomosCuba pic.twitter.com/LlgKGpXOuc
— Miguel Díaz-Canel Bermúdez (@DiazCanelB) February 21, 2021
‘Soberana 02 is being produced at a large scale at Biocen, a scientific institution attached to the BioCubaFarma entrepreneurial group and it has 30 years’ experience in vaccine production,’ the head of State tweeted.
Previously, BioCubaFarma had pointed out that the Cuban prototype is being produced at Biocen to be used in phase III of clinical trials that will start in March.
Group President Eduardo Martinez noted that the system is designed to product the other Cuban vaccine candidates at a large scale as soon as they are ready.
(Taken from Prensa Latina)